Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
02/15/2007 | WO2007017954A1 Maltose-1-phosphate-producing enzyme |
02/15/2007 | WO2007017915A2 Use of common ϝ chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes. |
02/15/2007 | WO2007017201A1 Generation of antigen specific t cells |
02/15/2007 | WO2007017050A2 Method for isolating stem cells and stem cells derived from a pad-like tissue of teeth |
02/15/2007 | WO2007016831A1 The production of many kinds of organisms, enzymes, cells, organs and technique thereof |
02/15/2007 | WO2007016792A1 Orf11 from campylobacter jejuni is a sialate-o-acetyltransferase |
02/15/2007 | WO2007016764A1 Composition and method for prevention and treatment of type i diabetes |
02/15/2007 | WO2006138005A8 Genes and uses for plant improvement |
02/15/2007 | WO2006128163A3 Transgenic alzheimer's mouse model vectors and uses thereof |
02/15/2007 | WO2006113731A9 Bone marrow-derived neurogenic cells and uses thereof |
02/15/2007 | WO2006104609A9 Isolated myeloid-like bone marrow cell populations and methods of treatment therewith |
02/15/2007 | WO2006073446A9 Peptide-mediated protein transduction into cells the hematopoietic lineage |
02/15/2007 | WO2006060769A3 Methods and materials for expression of a recombinant protein |
02/15/2007 | WO2005013904A3 Sars nucleic acids, proteins, vaccines, and uses thereof |
02/15/2007 | US20070039076 for generation of environmentally tailored crops; enhanced water and nitrogen use efficiency, cold tolerance, increased yield, enhanced seed protein and seed oil; nucleic acid molecule encoding a serine/threonine protein kinase |
02/15/2007 | US20070039073 Novel synthetic genes for plant gums |
02/15/2007 | US20070039071 Cell signaling genes and related methods |
02/15/2007 | US20070039070 transforming plant cells with a DNA construct comprising nucleic acid sequences, Eucalyptus caffeic acid 3-O-methyltransferase (COMT) promoters and nucleic acid sequence that code for polypeptides, then culturing said transformed plant cells, to producing transgenic plants |
02/15/2007 | US20070039068 High threonine producing lines of nicotiana tobacum and methods for producing |
02/15/2007 | US20070039067 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
02/15/2007 | US20070039064 Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse |
02/15/2007 | US20070039063 Trangenic diploid cell comprising mutation in kinase allele for use in screening modulator for treatment of anxiety, addiction, withdrawal syndrome, skeletal muscle spasms, convulsive seizures and epilepsy |
02/15/2007 | US20070038384 Devices and assays for monitoring/measuring cellular dynamics to create subject profiles from primary cells |
02/15/2007 | US20070037964 Chemoselective ligation |
02/15/2007 | US20070037745 Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer |
02/15/2007 | US20070037736 Therapeutic composition comprising the KAL protein and use of the KAL protein for the treatment of retinal, renal, neuronal and neural injury |
02/15/2007 | US20070037284 Vectors for expressing exogenous gene or exogenous nucleic acid sequences |
02/15/2007 | US20070037283 harvesting and purifying a renal capsule to provide an extracellular matrix material having beneficial use as a tissue graft and/or cell growth material |
02/15/2007 | US20070037282 Method of producing lens cell and lens cell obtained by the method |
02/15/2007 | US20070037281 Method for differentiating stem cells in cells that produce a pancreatic hormone |
02/15/2007 | US20070037280 Method for generating primate trophoblasts |
02/15/2007 | US20070037279 Cell culture system |
02/15/2007 | US20070037269 Mutants of desoxycytidine kinase having extended enzymatic activity |
02/15/2007 | US20070037255 Antibody variants with faster antigen association rates |
02/15/2007 | US20070037254 Expression Vectors and Methods |
02/15/2007 | US20070037251 Novel protein expression system |
02/15/2007 | US20070037245 Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis |
02/15/2007 | US20070037222 Lineage restricted glial precursors |
02/15/2007 | US20070037219 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof |
02/15/2007 | US20070037218 Human gene critical to fertility |
02/15/2007 | US20070037216 Dual expression vector system for antibody expression in bacterial and mammalian cells |
02/15/2007 | US20070037205 Methods and apparatus for cell based screening |
02/15/2007 | US20070037203 Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor |
02/15/2007 | US20070037202 Potentiation of cancer therapies by ZNF217 inhibition |
02/15/2007 | US20070037188 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's diseases; contacting a target cell with a test compound, measuring the levels of reporter gene transcription that occurs in the presence and absence of the test compound; comparing the levels of reporter gene transcription |
02/15/2007 | US20070037178 Endocrine cell lines and method of using the same |
02/15/2007 | US20070037145 drug screening; for carcinomas, especially lymphoma carcinomas |
02/15/2007 | US20070037136 Harvesting, separating, culturing and exposing tissue to antiproliferative agents, monitoring variation in tissue propagation; immunotherapeutics; wound healing agents |
02/15/2007 | US20070037132 Separation of platelets from fluid suspensions |
02/15/2007 | US20070036818 Fabricated in baculovirus; for penetration into human erythrocytes in event of infection; vaccines against malaria |
02/15/2007 | US20070036813 Expression vector comprising nucleotide sequences coding endothelial growth factor protein for use in prevention and treatment of cell proliferative and eye disorders |
02/15/2007 | US20070036796 For treating immunosuppressive diseases; AIDS |
02/15/2007 | US20070036794 Agonist anti-trkC monoclonal antibodies, directed against epitopes in extracellular domain of trkC receptor, which mimic biological activities of NT-3, the natural ligand of trkC receptor, but are free of some of known detriments of NT-3; use of theseagonist antibodies treatment of neuropathy |
02/15/2007 | US20070036788 Use of a compound for reducing the biological effectiveness of il-6 |
02/15/2007 | US20070036784 Medicament for the protection against thrombotic diseases |
02/15/2007 | US20070036783 Antibody complexes |
02/15/2007 | US20070036780 Modified proteins, designer toxins, and methods of making thereof |
02/15/2007 | US20070036774 Liver engrafting cells, assays, and uses thereof |
02/15/2007 | US20070036773 Generation and application of universal T cells for B-ALL |
02/15/2007 | US20070036772 Directed in vitro differentiation of marrow stromal cells into neural cell progenitors |
02/15/2007 | US20070036769 BMP pathway methods and compositions |
02/15/2007 | US20070036768 Systems and methods for treating patients with processed lipoaspirate cells |
02/15/2007 | US20070036767 Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
02/15/2007 | US20070036766 Tissue graft composition comprising autologous bone marrow and purified autologous thrombin |
02/15/2007 | US20070036763 Interleukin-17 receptor homologue |
02/15/2007 | US20070036756 Method for treating ischemic diseases |
02/15/2007 | US20070036734 Therapeutic agent for periodontal disease |
02/15/2007 | DE10336152B4 Aufreinigungsverfahren für humane mesenchymale Stammzellen Purification method for human mesenchymal stem cells |
02/15/2007 | DE102006025680A1 Herstellung multipotenter Stammzellen und deren Verwendung Production of multipotent stem cells and their use |
02/15/2007 | CA2659945A1 Improved methods of reprogramming animal somatic cells |
02/15/2007 | CA2658678A1 Composition and method for prevention and treatment of type i diabetes |
02/15/2007 | CA2619443A1 Glypican-3 (gpc3)-derived tumor rejection antigenic peptides useful for hla-a2-positive patients and pharmaceutical comprising the same |
02/15/2007 | CA2618769A1 Orf11 from campylobacter jejuni is a sialate-o-acetyltransferase |
02/15/2007 | CA2618580A1 Use of common .gamma. chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes |
02/15/2007 | CA2617483A1 Modified influenza virus for monitoring and improving vaccine efficiency |
02/15/2007 | CA2616437A1 Method for isolating stem cells and stem cells derived from a pad-like tissue of teeth |
02/15/2007 | CA2616069A1 Suppression of b-cell apoptosis in transgenic animals expressing humanized immunoglobulin |
02/14/2007 | EP1752540A2 Non-human mutant mammals deficient in sigma receptors and their applications |
02/14/2007 | EP1752168A2 Augmentation of organ function |
02/14/2007 | EP1752163A1 Agent for actively restoring structure and functions of damaged tissues and organs |
02/14/2007 | EP1752160A2 Epitope sequences |
02/14/2007 | EP1751661A2 Method for selectively expanding, selecting and enriching stem/progenitor cell populations |
02/14/2007 | EP1751291A1 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
02/14/2007 | EP1751290A2 Alphavirus replicon packaging constructs |
02/14/2007 | EP1751289A1 Tc-83-derived alphavirus vectors, particles and methods |
02/14/2007 | EP1751282A2 Production of host cells containing mutiple integrating vectors by serial transduction |
02/14/2007 | EP1751280A2 Tobacco nicotine demethylase genomic clone and uses thereof |
02/14/2007 | EP1751274A1 Method for producing pluripotent cells from monocytesmethod for producing pluripotent cells from monocytes |
02/14/2007 | EP1751267A1 Patterned cell network substrate interface and methods and uses thereof |
02/14/2007 | EP1751191A2 Antibodies to angiogenesis inhibiting domains of cd148 |
02/14/2007 | EP1751187A2 Canine cd20 compositions |
02/14/2007 | EP1750791A2 Devices and methods for protecting against distal embolisms |
02/14/2007 | EP1750773A1 Drugs for the prevention or treatment of immunodeficiencies, autoimmune diseases or for the induction of immune tolerance |
02/14/2007 | EP1750764A2 Antibodies of angiogenesis inhibiting domains of cd148 |
02/14/2007 | EP1750497A2 A method for producing direct in vitro flowering and viable seed from cotyledon, radicle, and leaf explants and plants produced therefrom |
02/14/2007 | EP1689878A4 Method for maintaining low shear in a bioprocessing system |
02/14/2007 | EP1565737A4 Isolation of sperm cells from other biological materials using microfabricated devices and related methods thereof |
02/14/2007 | EP1546388A4 Real time measurement of cellular responses |
02/14/2007 | EP1328645B1 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
02/14/2007 | EP1326673B1 Microstructures for treating and conditioning skin |